BAP Ex-Officio Member Details

Back to Council Page

David Nutt Editor-in-Chief of BAP Journal of Psychopharmacology: Professor David Nutt, DM, FRCP, FRCPsych, FMedSci

University of Bristol. david.j.nutt@bristol.ac.uk
Current Editor

David Nutt is currently the Edmund J Safra Professor of Neuropsychopharmacology and Head of the Department of Neuropsychopharmacology and Molecular Imaging at Imperial College London.

He received his undergraduate training in medicine at Cambridge and Guy's Hospital, and continued training in neurology to MRCP. After completing his psychiatric training in Oxford, he continued there as a lecturer and then later as a Wellcome Senior Fellow in psychiatry. He then spent two years as Chief of the Section of Clinical Science in the National Institute of Alcohol Abuse and Alcoholism in NIH, Bethesda, USA. On returning to England in 1988 he set up the Psychopharmacology Unit in Bristol, an interdisciplinary research grouping spanning the departments of Psychiatry and Pharmacology before moving to Imperial College London in December 2008.

He is currently Chair of the Advisory Council on the Misuse of Drugs (ACMD) and President of the European College of Neuropsychopharmacology (ECNP), UK Director of the ‘European Certificate in Anxiety and Mood Disorders’ and the ‘Masters in Affective Disorders’ Courses jointly administered by the Universities of Maastricht, Bristol and Florence. In addition, he is the Editor of the Journal of Psychopharmacology, advisor to the British National Formulary and on the MRC Neuroscience Board.

Previously he has been President of the British Association of Psychopharmacology (BAP), member of the HEFCE/NHS Senior Lecturer Selection Panel as well as an advisor to the MHRN on clinical drug trials. Other previous national contributions include membership of the Independent Inquiry into the Misuse of Drugs Act, chaired by Viscountess Runciman that reported in 2000 and membership of the Committee on Safety of Medicines (CSM) from 2000 – 2005. In 2004-2005 he was the clinical scientific lead on the UK Government Foresight initiative “Brain science, addiction and drugs” that provided a 25-year vision for this area of science and public policy. In 2006 he was Director of Bristol Neuroscience.

He broadcasts widely to the general public both on radio and television including a recent BBC Horizon on drug harms and their classification. He also lecturers widely to the public as well as to the scientific and medical communities; for instance has presented twice at the Cheltenham Science Festival and several times for Café Scientifiques.

Latest News

Subscribe to the News Feed rss feed

  1. InVivoStat Statistical Analysis on 23rd August 2010
    New BAP Education web page describing InVivoStat: The Statistical Tool for all Psychopharmacologists. Click here to read more InVivoStat
  2. Information for the Public on 4th August 2010
    We are pleased to launch our Public Web Pages. These are intended for members of the public with an interest in psychopharmacology. Public Web Page
  3. Review of Mental Health Research on 5th July 2010
    In 2009, BAP contributed to the Medical Research Council’s Review of Mental Health Research. The Report has recently been published. A summary report may be found here; MRC Mental Health Research Summary Report. Professor Barbara Sahakian, who will become BAP President-elect later this month, has written an article in the Lancet “A UK strategy for mental health and wellbeing”, also available here; Lancet article

See more news